Antibodies formed by Sinovac Biotech’s Covid-19 vaccine drop below a key threshold from around six months after a second dose for most recipients, although a third shot could have a strong boosting impact, a lab study has revealed.
According to details, Chinese researchers reported the results from a study of blood samples from healthy adults aged between 18-59 in a paper published on Sunday, which has not been peer-reviewed, reports Reuters.
For participants receiving two doses, two or four weeks apart, only 16.9% and 35.2% respectively still had a level of neutralising antibodies above the threshold six months after the second dose, the paper said.
Read More: Covid vaccination certificate necessary for domestic air travel from August 1
Those readings were based on data from two groups involving more than 50 participants each, while the study gave third doses to a total of 540 participants.
When participants in some cohorts were given a third dose, about six months after the second, neutralising antibody levels after a further 28 days had increased around 3-5 fold from the levels seen four weeks after the second dose, the study showed.
The study was conducted by researchers at disease control authorities in Jiangsu province, Sinovac, and other Chinese institutions.
Researchers notified the study did not test the antibodies’ effect against more contagious variants, and that further research was required to assess antibody duration after a third shot.
